IP10 and anti-HBc can predict virological relapse and HBsAg loss in chronic hepatitis B patients after nucleos(t)ide analogue discontinuation.

IF 2 4区医学 Q3 GASTROENTEROLOGY & HEPATOLOGY

Digestive Diseases Pub Date : 2023-06-01 DOI:10.1016/s0168-8278(23)03167-7

Yandi Xie, Minghui Li, X. Ou, S. Zheng, Yinjie Gao, Xiaoyuan Xu, Yingsi Yang, A. Ma, Jia Li, Y. Nan, Huan‐wei Zheng, Juan Liu, Lai Wei, B. Feng

引用次数: 0

查看原文本刊更多论文

IP10和抗hbc可以预测核苷类似物停药后慢性乙型肝炎患者的病毒学复发和HBsAg损失。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Digestive Diseases 医学-胃肠肝病学

CiteScore

4.80

自引率

0.00%

发文量

审稿时长

2 months

期刊介绍： Each issue of this journal is dedicated to a special topic of current interest, covering both clinical and basic science topics in gastrointestinal function and disorders. The contents of each issue are comprehensive and reflect the state of the art, featuring editorials, reviews, mini reviews and original papers. These individual contributions encompass a variety of disciplines including all fields of gastroenterology. ''Digestive Diseases'' bridges the communication gap between advances made in the academic setting and their application in patient care. The journal is a valuable service for clinicians, specialists and physicians-in-training.